National Jewish Health 61st Annual Denver TB Course 2025
Comprehensive Tuberculosis, Latent TB Infection, Drug-Resistant TB & Global TB Control Update
The National Jewish Health 61st Annual Denver TB Course 2025 is one of the world’s most respected and longest-running educational programs dedicated exclusively to the diagnosis, treatment, prevention, and public health management of Tuberculosis (TB). Developed and delivered by internationally recognized tuberculosis experts from National Jewish Health, this comprehensive course provides clinicians with the latest evidence-based strategies for managing both common and complex TB cases in modern clinical practice.
As tuberculosis continues to pose a major global health challenge, healthcare professionals must remain current with evolving diagnostic technologies, treatment regimens, drug-resistance patterns, and public health interventions. This intensive educational program reviews contemporary approaches to active TB disease, latent tuberculosis infection (LTBI), multidrug-resistant tuberculosis (MDR-TB), extensively drug-resistant tuberculosis (XDR-TB), and TB management in special populations including patients with HIV infection and immunocompromising conditions.
Through expert-led lectures, real-world case discussions, and guideline-focused updates, participants gain practical clinical knowledge applicable to both individual patient care and broader public health initiatives.
Course Details
Course: National Jewish Health 61st Annual Denver TB Course 2025
Institution: National Jewish Health
Format: Videos Only
Educational Level: Intermediate to Advanced
Access: On-Demand
Program Overview
This internationally recognized course delivers an in-depth review of tuberculosis across the entire spectrum of disease prevention, diagnosis, treatment, and public health control.
The curriculum focuses on:
- Active tuberculosis diagnosis
- Latent tuberculosis infection (LTBI)
- Tuberculosis epidemiology
- Drug-resistant tuberculosis
- MDR-TB and XDR-TB
- HIV-associated TB
- Pediatric tuberculosis
- TB infection control
- Public health interventions
- Contact investigations
- Tuberculosis screening programs
- Emerging diagnostic technologies
- Modern treatment regimens
- Global tuberculosis challenges
Participants gain practical skills for managing TB in both low-incidence and high-incidence settings while reviewing current national and international guidelines.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Apply evidence-based strategies for diagnosing active tuberculosis.
- Differentiate latent TB infection from active disease.
- Utilize modern laboratory and imaging tools in TB evaluation.
- Develop treatment plans for drug-susceptible tuberculosis.
- Recognize and manage multidrug-resistant and extensively drug-resistant TB.
- Implement appropriate TB screening and prevention strategies.
- Manage tuberculosis in HIV-positive and immunocompromised patients.
- Apply public health principles to TB control and outbreak management.
- Interpret current guidelines for latent TB treatment.
- Improve patient adherence and treatment completion rates.
Tuberculosis Diagnosis
A major focus of the course is improving diagnostic accuracy through modern TB testing strategies.
Topics include:
- Clinical presentation of tuberculosis
- Pulmonary TB
- Extrapulmonary TB
- Chest imaging interpretation
- Sputum analysis
- Acid-fast bacilli (AFB) testing
- Mycobacterial cultures
- Nucleic acid amplification tests (NAAT)
- Interferon-gamma release assays (IGRAs)
- Tuberculin skin testing (TST)
Faculty review diagnostic algorithms and discuss practical approaches to challenging cases.
Latent Tuberculosis Infection (LTBI)
Early identification and treatment of LTBI remain essential for TB elimination efforts.
Coverage includes:
- LTBI screening recommendations
- Risk assessment
- Diagnostic testing
- Treatment indications
- Short-course LTBI regimens
- Rifamycin-based therapies
- Monitoring and follow-up
- Prevention of disease progression
Participants learn how to effectively identify and treat individuals at risk for future active disease.
Drug-Resistant Tuberculosis
The course provides detailed reviews of multidrug-resistant and extensively drug-resistant tuberculosis.
Topics include:
- MDR-TB diagnosis
- XDR-TB management
- Drug susceptibility testing
- Treatment selection
- Novel anti-TB medications
- Combination therapy approaches
- Adverse event monitoring
- Treatment adherence strategies
Faculty discuss evolving global resistance patterns and contemporary management recommendations.
Tuberculosis in HIV & Immunocompromised Patients
Special attention is given to managing TB in vulnerable patient populations.
Key topics include:
- HIV-associated tuberculosis
- TB screening in HIV patients
- Antiretroviral therapy considerations
- Immune reconstitution inflammatory syndrome (IRIS)
- Solid organ transplant recipients
- Biologic therapy recipients
- Oncology patients
- Other immunocompromised populations
Participants review evidence-based approaches to balancing TB treatment with immunosuppressive therapies.
Pediatric Tuberculosis
The program also addresses unique challenges in childhood TB management.
Topics include:
- Pediatric TB diagnosis
- Exposure evaluation
- Latent TB in children
- Treatment protocols
- Contact investigations
- Vaccination considerations
- Special pediatric populations
Faculty discuss age-specific approaches and diagnostic challenges commonly encountered in clinical practice.
Public Health & Global TB Control
A defining feature of the Denver TB Course is its emphasis on public health and global disease control.
Coverage includes:
- TB epidemiology
- Contact tracing
- Outbreak investigations
- Community screening programs
- Infection prevention
- Healthcare-associated transmission
- Global TB initiatives
- Elimination strategies
Participants gain a broader understanding of tuberculosis control beyond individual patient management.
Infection Prevention & Control
Preventing transmission remains a cornerstone of TB management.
Topics include:
- Airborne precautions
- Isolation protocols
- Healthcare worker protection
- Environmental controls
- Respiratory protection programs
- Hospital-based infection control
- Community prevention measures
Practical guidance is provided for implementing effective infection control policies.
Key Topics Covered
chek list of videos
Target Audience
- Pulmonologists
- Infectious Disease specialists
- Internal Medicine doctors
- Residents / Medical students
- Public health professionals
Why This Course
- Globally recognized TB training program
- Practical, clinic-oriented approach
- Covers both US guidelines + global perspective
videos
| Sr. No. | Title | Duration | Speaker |
|---|---|---|---|
| 1 | LTBI Treatment and BCG Vaccine | 52:42 | Stephanie Wienkers |
| 2 | Updates in the Management of TB Infection and Disease in People Living with HIV | 46:48 | Michelle Haas |
| 3 | Michael D. Iseman Annual Lectureship: Improving Tuberculosis Diagnostic Services in High Burden Countries | 46:51 | Adithya Cattamanchi |
| 4 | Management of MDR-TB | 52:44 | Charles Daley |
| 5 | Management of Substance Use Disorders in the TB Clinic: Making the Case for Creating a Context of Concurrent Care | 33:17 | Hermione Hurley |








